Wall Street analysts will be watching closely when MetLife, Inc. (NYSE:MET) reports its quarterly earnings next, which is scheduled for Wed 1 May (In 15 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $1.34 per share. In the preceding quarter, the company reportedly generated EPS of $1.35 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 10.90%, a profit margin of 7.30% and a gross margin of .
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of MetLife, Inc. (NYSE:MET). Most recently, on March 19th, 2019, Sandler O’Neill Downgrade a Hold rating. Before that, on January 16th, 2019, BofA/Merrill Upgrade to Buy. Sandler O’Neill Upgrade a Buy rating on January 2nd, 2019, Goldman Downgrade an Neutral rating on June 4th, 2018, and Credit Suisse Initiated a Outperform rating on April 25th, 2018.
At its current price point, combined with the fact that this company has 950.47M shares outstanding, the current market capitalization sits at 43.90B. In the last trading day, 5,188,722 shares of MetLife, Inc. were traded, which compares to its usual volume of about 5.70M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $1.89 in the past five trading days, resulting in a percentage change of +4.27% and a moving average of 45.48. In the past 20 days, its price changed by $1.15 (which is +2.55%) and the stock’s moving average was 43.95. Looking back a full 50 days, shares of MET changed by $1.03 (which is +2.28%) and demonstrated a moving average of 44.41.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 70.77%, a 14-day Stochastic %K score of 83.35% and a 20-day Stochastic %K score of 85.09%. Using a similar metric, MetLife, Inc. (MET) shares showed a Stochastic %D of 74.84% over the past 9 days, a Stochastic %D score of 85.03% over the last 14 days, and a 20-day Stochastic %D of 81.79%. Meanwhile, this stock’s MACD Oscillator was 0.60 over the past 9 days, 1.21 over the past two weeks, and 1.82 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $46.19 level. Over the past 12 months, this stock has experienced a high price of $48.92 and a low of $37.76. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
The Vanguard Group Inc purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from MetLife, Inc. (NYSE:MET) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 66,196,593 shares of the company’s stock following the addition of 1,229,037 to this investor’s holdings during the three-month period. This share count represents that The Vanguard Group Inc now held 6.92% stake in MetLife, Inc. (MET)’s shares.
Just in the most recent trading day, MetLife, Inc. (NYSE:MET) experienced a high price of $46.34 and low point of $45.39. At the end of the last trading session, this stock was at 46.19 per share, following a loss of -$45.25, or 2.08% during the full day.